Clinical Scorecard: The association of white matter hyperintensity severity with gait abnormalities in individuals suffering from cerebral small vessel disease
At a Glance
Category
Detail
Condition
Cerebral small vessel disease (CSVD)
Key Mechanisms
White matter hyperintensity (WMH) severity affecting gait parameters
Target Population
Patients with CSVD and independent walking ability
Care Setting
Neurology Department, Tianjin Huanhu Hospital
Key Highlights
335 patients with CSVD were enrolled in the study.
Moderate-to-severe WMH was associated with slower gait speed and shorter stride length.
Toe-off angle and swing-phase coefficient of variation were identified as independent risk factors for gait impairment.
Increased gait-parameter symmetry and variability were observed in patients with moderate-to-severe WMH.
Guideline-Based Recommendations
Diagnosis
Use the Fazekas scale for assessing WMH severity on MRI.
Management
Monitor gait parameters in patients with CSVD to identify gait impairment.
Monitoring & Follow-up
Regular assessment of gait speed, stride length, and toe-off angle.
Risks
Increased risk of falls and disabilities associated with gait disorders in CSVD patients.
Patient & Prescribing Data
Patients with cerebral small vessel disease who can walk independently.
Focus on gait analysis and monitoring WMH severity to manage gait-related issues.
Clinical Best Practices
Incorporate wearable gait analysis systems for detailed evaluation of gait parameters.
Assess both spatiotemporal and kinematic measures of gait in patients with CSVD.
